home.aspx

 
.

OVERCOMING DRUG RESISTANCE PATTERNS IN NON-RESPONDERS: PROVEN BEST PRACTICES ON INFORMING YOUR CLINICAL STRATEGY

SHARESHARESHARE
Many standard of care (SOC) treatments in cancer patients result in a clinical outcome of non-response. Drug development companies are trending toward interrogating resistance mechanisms and using this information in advancing their programs and informing personalized approaches to novel therapeutics.